Douglas Owens

Affiliations: 
Stanford University, Palo Alto, CA 
Google:
"Douglas Owens"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sceats LA, Ku S, Coughran A, et al. (2019) Operative Versus Nonoperative Management of Appendicitis: A Long-Term Cost Effectiveness Analysis. Mdm Policy & Practice. 4: 2381468319866448
Lin JK, Lerman BJ, Barnes JI, et al. (2018) Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018790642
Barnes JI, Divi V, Begaye A, et al. (2018) Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p. Blood Advances. 2: 1946-1956
Itoga NK, Minami HR, Chelvakumar M, et al. (2018) Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vascular Medicine (London, England). 1358863X17745371
Harris JP, Saraswathula A, Kaplun BD, et al. (2018) Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma with Plasma Epstein-Barr Virus DNA International Journal of Radiation Oncology Biology Physics. 102
Pollom E, Lee K, Durkee BY, et al. (2016) Cost-Effectiveness of Local Therapies for Inoperable, Localized Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics. 96: E138
Freeman JV, Hutton DW, Barnes GD, et al. (2016) Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circulation. Arrhythmia and Electrophysiology. 9
Khazeni N, Hutton DW, Collins CI, et al. (2014) Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Annals of Internal Medicine. 160: 684-94
Kazi DS, Garber AM, Shah RU, et al. (2014) Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Annals of Internal Medicine. 160: 221-32
Simons CT, Cipriano LE, Shah RU, et al. (2013) Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circulation. Cardiovascular Quality and Outcomes. 6: 419-28
See more...